Il peut être proposé aux patients présentant des douleurs neuropathiques centrales rebelles (post-AVC, …) des séances de rTMS (résonnance magnétique transcrânienne).
Cette technique de neuromodulation repose sur l’utilisation d’un champ magnétique appliqué sur le cortex à l’aide d’une bobine. Divers paramètres de stimulation sont utilisés, en particulier la fréquence haute ou basse, selon que l’on recherche un effet stimulant ou inhibiteur de zones cérébrales précises impliquées dans la modulation de la douleur. L’intensité de la stimulation est calculée en fonction du seuil moteur qui correspond à l’excitabilité du cortex moteur d’un sujet donné.
Cela se réalise en ambulatoire, sur le CHS Esquirol, en partenariat avec le CHU de Limoges.
Références scientifiques
1954841
{1954841:FAIWLFE4},{1954841:I87XCB4E},{1954841:M8EJD8TK}
1
chicago-fullnote-bibliography
50
date
196
https://cabinetdouleurlimoges.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22I87XCB4E%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Goto%20et%20al.%22%2C%22parsedDate%22%3A%222020-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGoto%2C%20Yuko%2C%20Koichi%20Hosomi%2C%20Toshio%20Shimokawa%2C%20Takeshi%20Shimizu%2C%20Kiyoshi%20Yoshino%2C%20Seung%20Jin%20Kim%2C%20Tomoo%20Mano%2C%20Haruhiko%20Kishima%2C%20and%20Youichi%20Saitoh.%20%26%23x201C%3BPilot%20Study%20of%20Repetitive%20Transcranial%20Magnetic%20Stimulation%20in%20Patients%20with%20Chemotherapy-Induced%20Peripheral%20Neuropathy.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Neuroscience%26lt%3B%5C%2Fi%26gt%3B%2073%20%28March%201%2C%202020%29%3A%20101%26%23x2013%3B7.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jocn.2020.01.020%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jocn.2020.01.020%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pilot%20study%20of%20repetitive%20transcranial%20magnetic%20stimulation%20in%20patients%20with%20chemotherapy-induced%20peripheral%20neuropathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuko%22%2C%22lastName%22%3A%22Goto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koichi%22%2C%22lastName%22%3A%22Hosomi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshio%22%2C%22lastName%22%3A%22Shimokawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Shimizu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%22%2C%22lastName%22%3A%22Yoshino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seung%20Jin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomoo%22%2C%22lastName%22%3A%22Mano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruhiko%22%2C%22lastName%22%3A%22Kishima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Youichi%22%2C%22lastName%22%3A%22Saitoh%22%7D%5D%2C%22abstractNote%22%3A%22Objective%5CnChemotherapy-induced%20peripheral%20neuropathy%20%28CIPN%29%20is%20one%20of%20the%20intractable%20long-term%20side%20effects%20of%20anticancer%20medications%20and%20results%20in%20pain%20and%20dysesthesia.%20Repetitive%20transcranial%20magnetic%20stimulation%20%28rTMS%29%20of%20the%20primary%20motor%20cortex%20has%20been%20demonstrated%20to%20provide%20effective%20relief%20for%20intractable%20neuropathic%20pain.%20The%20objective%20of%20this%20study%20was%20to%20investigate%20the%20effects%20of%20rTMS%20treatment%20on%20CIPN%20in%20cancer%20patients.%5CnMaterials%20and%20methods%5CnEleven%20female%20patients%20with%20breast%20cancer%20or%20gynecologic%20cancer%20%28mean%20age%2064.8%20%5Bstandard%20deviation%207.8%5D%29%20who%20had%20neuropathic%20pain%20and%5C%2For%20peripheral%20sensory%20neuropathy%2C%20with%20a%20minimum%20two%20grade%20severity%20based%20on%20the%20scale%20of%20the%20National%20Cancer%20Institutes%5Cu2019%20Common%20Terminology%20Criteria%20for%20Adverse%20Events%20%28version%204.0%29%20were%20enrolled.%20Patients%20received%20rTMS%20%285-Hz%3B%20500%20pulses%5C%2Fsession%3B%20figure-8%20coil%29%20on%20their%20primary%20motor%20cortex%20corresponding%20to%20the%20target%20extremity.%20The%20intensity%20of%20pain%20and%20dysesthesia%20for%20all%20extremities%20was%20evaluated%20using%20a%20visual%20analog%20scale%20for%20pain%2C%20dysesthesia%2C%20and%20the%20Japanese%20version%20of%20the%20short-form%20McGill%20Pain%20Questionnaire%202%20%28SFMPQ2%29.%5CnResults%5CnrTMS%20for%20target%20extremity%20significantly%20decreased%20the%20visual%20analog%20scale%20of%20pain%20and%20dysesthesia.%20The%20intensity%20of%20pain%20measured%20by%20the%20SFMPQ2%20was%20also%20decreased%20in%20the%20target%20extremity.%20Regarding%20non-target%20extremities%2C%20only%20dysesthesia%20significantly%20decreased%20as%20a%20result%20of%20rTMS.%20No%20adverse%20events%20were%20observed.%5CnConclusion%5CnThis%20is%20an%20initial%20report%20demonstrating%20the%20potential%20of%20rTMS%20for%20the%20treatment%20of%20CIPN.%20We%20suggest%20rTMS%20could%20be%20potentially%20beneficial%20and%20effective%20as%20a%20treatment%20for%20pain%20and%20dysesthesia%20in%20patients%20with%20CIPN.%22%2C%22date%22%3A%22March%201%2C%202020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jocn.2020.01.020%22%2C%22ISSN%22%3A%220967-5868%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0967586819319472%22%2C%22collections%22%3A%5B%22MKG94YEE%22%5D%2C%22dateModified%22%3A%222020-04-21T11%3A49%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22FAIWLFE4%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lefaucheur%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLefaucheur%2C%20Jean-Pascal%2C%20Andr%26%23xE9%3B%20Aleman%2C%20Chris%20Baeken%2C%20David%20H.%20Benninger%2C%20J%26%23xE9%3Br%26%23xF4%3Bme%20Brunelin%2C%20Vincenzo%20Di%20Lazzaro%2C%20Sa%26%23x161%3Ba%20R.%20Filipovi%26%23x107%3B%2C%20et%20al.%20%26%23x201C%3BEvidence-Based%20Guidelines%20on%20the%20Therapeutic%20Use%20of%20Repetitive%20Transcranial%20Magnetic%20Stimulation%20%28rTMS%29%3A%20An%20Update%20%282014%26%23x2013%3B2018%29.%26%23x201D%3B%20%26lt%3Bi%26gt%3BClinical%20Neurophysiology%26lt%3B%5C%2Fi%26gt%3B%20131%2C%20no.%202%20%28February%201%2C%202020%29%3A%20474%26%23x2013%3B528.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.clinph.2019.11.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.clinph.2019.11.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evidence-based%20guidelines%20on%20the%20therapeutic%20use%20of%20repetitive%20transcranial%20magnetic%20stimulation%20%28rTMS%29%3A%20An%20update%20%282014%5Cu20132018%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pascal%22%2C%22lastName%22%3A%22Lefaucheur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9%22%2C%22lastName%22%3A%22Aleman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Baeken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20H.%22%2C%22lastName%22%3A%22Benninger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Brunelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincenzo%22%2C%22lastName%22%3A%22Di%20Lazzaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sa%5Cu0161a%20R.%22%2C%22lastName%22%3A%22Filipovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Grefkes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alkomiet%22%2C%22lastName%22%3A%22Hasan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedhelm%20C.%22%2C%22lastName%22%3A%22Hummel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satu%20K.%22%2C%22lastName%22%3A%22J%5Cu00e4%5Cu00e4skel%5Cu00e4inen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berthold%22%2C%22lastName%22%3A%22Langguth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Letizia%22%2C%22lastName%22%3A%22Leocani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Londero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raffaele%22%2C%22lastName%22%3A%22Nardone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Paul%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Nyffeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albino%20J.%22%2C%22lastName%22%3A%22Oliveira-Maia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Oliviero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Padberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulrich%22%2C%22lastName%22%3A%22Palm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walter%22%2C%22lastName%22%3A%22Paulus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Poulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%22%2C%22lastName%22%3A%22Quartarone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fady%22%2C%22lastName%22%3A%22Rachid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irena%22%2C%22lastName%22%3A%22Rektorov%5Cu00e1%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Rossi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%22%2C%22lastName%22%3A%22Sahlsten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Schecklmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Szekely%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulf%22%2C%22lastName%22%3A%22Ziemann%22%7D%5D%2C%22abstractNote%22%3A%22A%20group%20of%20European%20experts%20reappraised%20the%20guidelines%20on%20the%20therapeutic%20efficacy%20of%20repetitive%20transcranial%20magnetic%20stimulation%20%28rTMS%29%20previously%20published%20in%202014%20%5BLefaucheur%20et%20al.%2C%20Clin%20Neurophysiol%202014%3B125%3A2150%5Cu2013206%5D.%20These%20updated%20recommendations%20take%20into%20account%20all%20rTMS%20publications%2C%20including%20data%20prior%20to%202014%2C%20as%20well%20as%20currently%20reviewed%20literature%20until%20the%20end%20of%202018.%20Level%20A%20evidence%20%28definite%20efficacy%29%20was%20reached%20for%3A%20high-frequency%20%28HF%29%20rTMS%20of%20the%20primary%20motor%20cortex%20%28M1%29%20contralateral%20to%20the%20painful%20side%20for%20neuropathic%20pain%3B%20HF-rTMS%20of%20the%20left%20dorsolateral%20prefrontal%20cortex%20%28DLPFC%29%20using%20a%20figure-of-8%20or%20a%20H1-coil%20for%20depression%3B%20low-frequency%20%28LF%29%20rTMS%20of%20contralesional%20M1%20for%20hand%20motor%20recovery%20in%20the%20post-acute%20stage%20of%20stroke.%20Level%20B%20evidence%20%28probable%20efficacy%29%20was%20reached%20for%3A%20HF-rTMS%20of%20the%20left%20M1%20or%20DLPFC%20for%20improving%20quality%20of%20life%20or%20pain%2C%20respectively%2C%20in%20fibromyalgia%3B%20HF-rTMS%20of%20bilateral%20M1%20regions%20or%20the%20left%20DLPFC%20for%20improving%20motor%20impairment%20or%20depression%2C%20respectively%2C%20in%20Parkinson%5Cu2019s%20disease%3B%20HF-rTMS%20of%20ipsilesional%20M1%20for%20promoting%20motor%20recovery%20at%20the%20post-acute%20stage%20of%20stroke%3B%20intermittent%20theta%20burst%20stimulation%20targeted%20to%20the%20leg%20motor%20cortex%20for%20lower%20limb%20spasticity%20in%20multiple%20sclerosis%3B%20HF-rTMS%20of%20the%20right%20DLPFC%20in%20posttraumatic%20stress%20disorder%3B%20LF-rTMS%20of%20the%20right%20inferior%20frontal%20gyrus%20in%20chronic%20post-stroke%20non-fluent%20aphasia%3B%20LF-rTMS%20of%20the%20right%20DLPFC%20in%20depression%3B%20and%20bihemispheric%20stimulation%20of%20the%20DLPFC%20combining%20right-sided%20LF-rTMS%20%28or%20continuous%20theta%20burst%20stimulation%29%20and%20left-sided%20HF-rTMS%20%28or%20intermittent%20theta%20burst%20stimulation%29%20in%20depression.%20Level%20A%5C%2FB%20evidence%20is%20not%20reached%20concerning%20efficacy%20of%20rTMS%20in%20any%20other%20condition.%20The%20current%20recommendations%20are%20based%20on%20the%20differences%20reached%20in%20therapeutic%20efficacy%20of%20real%20vs.%20sham%20rTMS%20protocols%2C%20replicated%20in%20a%20sufficient%20number%20of%20independent%20studies.%20This%20does%20not%20mean%20that%20the%20benefit%20produced%20by%20rTMS%20inevitably%20reaches%20a%20level%20of%20clinical%20relevance.%22%2C%22date%22%3A%22February%201%2C%202020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.clinph.2019.11.002%22%2C%22ISSN%22%3A%221388-2457%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1388245719312799%22%2C%22collections%22%3A%5B%22MKG94YEE%22%5D%2C%22dateModified%22%3A%222020-04-21T11%3A49%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22M8EJD8TK%22%2C%22library%22%3A%7B%22id%22%3A1954841%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leung%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLeung%2C%20Albert%2C%20Prasad%20Shirvalkar%2C%20Robert%20Chen%2C%20Joshua%20Kuluva%2C%20Michael%20Vaninetti%2C%20Richard%20Bermudes%2C%20Lawrence%20Poree%2C%20Eric%20Wassermann%2C%20Brian%20Kopell%2C%20and%20Robert%20Levy.%20%26%23x201C%3BTranscranial%20Magnetic%20Stimulation%20for%20Pain%2C%20Headache%2C%20and%20Comorbid%20Depression%3A%20INS-NANS%20Expert%20Consensus%20Panel%20Review%20and%20Recommendation.%26%23x201D%3B%20%26lt%3Bi%26gt%3BNeuromodulation%3A%20Technology%20at%20the%20Neural%20Interface%26lt%3B%5C%2Fi%26gt%3B%20n%5C%2Fa%2C%20no.%20n%5C%2Fa.%20Accessed%20April%2021%2C%202020.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fner.13094%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fner.13094%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcranial%20Magnetic%20Stimulation%20for%20Pain%2C%20Headache%2C%20and%20Comorbid%20Depression%3A%20INS-NANS%20Expert%20Consensus%20Panel%20Review%20and%20Recommendation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prasad%22%2C%22lastName%22%3A%22Shirvalkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Kuluva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Vaninetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Bermudes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Poree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Wassermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Kopell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Levy%22%7D%5D%2C%22abstractNote%22%3A%22Background%20While%20transcranial%20magnetic%20stimulation%20%28TMS%29%20has%20been%20studied%20for%20the%20treatment%20of%20psychiatric%20disorders%2C%20emerging%20evidence%20supports%20its%20use%20for%20pain%20and%20headache%20by%20stimulating%20either%20motor%20cortex%20%28M1%29%20or%20dorsolateral%20prefrontal%20cortex%20%28DLPFC%29.%20However%2C%20its%20clinical%20implementation%20is%20hindered%20due%20to%20a%20lack%20of%20consensus%20in%20the%20quality%20of%20clinical%20evidence%20and%20treatment%20recommendation%5C%2Fguideline%28s%29.%20Thus%2C%20working%20collaboratively%2C%20this%20multinational%20multidisciplinary%20expert%20panel%20aims%20to%3A%201%29%20assess%20and%20rate%20the%20existing%20outcome%20evidence%20of%20TMS%20in%20various%20pain%5C%2Fheadache%20conditions%3B%202%29%20provide%20TMS%20treatment%20recommendation%5C%2Fguidelines%20for%20the%20evaluated%20conditions%20and%20comorbid%20depression%3B%20and%203%29%20assess%20the%20cost-effectiveness%20and%20technical%20issues%20relevant%20to%20the%20long-term%20clinical%20implementation%20of%20TMS%20for%20pain%20and%20headache.%20Methods%20Seven%20task%20groups%20were%20formed%20under%20the%20guidance%20of%20a%205-member%20steering%20committee%20with%20four%20task%20groups%20assessing%20the%20utilization%20of%20TMS%20in%20the%20treatment%20of%20Neuropathic%20Pain%20%28NP%29%2C%20Acute%20Pain%2C%20Primary%20Headache%20Disorders%2C%20and%20Posttraumatic%20Brain%20Injury%20related%20Headaches%20%28PTBI-HA%29%2C%20and%20remaining%20three%20assessing%20the%20treatment%20for%20both%20pain%20and%20comorbid%20depression%2C%20and%20the%20cost-effectiveness%20and%20technological%20issues%20relevant%20to%20the%20treatment.%20Results%20The%20panel%20rated%20the%20overall%20level%20of%20evidence%20and%20recommendability%20for%20clinical%20implementation%20of%20TMS%20as%3A%201%29%20high%20and%20extremely%5C%2Fstrongly%20for%20both%20NP%20and%20PTBI-HA%20respectively%3B%202%29%20moderate%20for%20postoperative%20pain%20and%20migraine%20prevention%2C%20and%20recommendable%20for%20migraine%20prevention.%20While%20the%20use%20of%20TMS%20for%20treating%20both%20pain%20and%20depression%20in%20one%20setting%20is%20clinically%20and%20financially%20sound%2C%20more%20studies%20are%20required%20to%20fully%20assess%20the%20long-term%20benefit%20of%20the%20treatment%20for%20the%20two%20highly%20comorbid%20conditions%2C%20especially%20with%20neuronavigation.%20Conclusions%20After%20extensive%20literature%20review%2C%20the%20panel%20provided%20recommendations%20and%20treatment%20guidelines%20for%20TMS%20in%20managing%20neuropathic%20pain%20and%20headaches.%20In%20addition%2C%20the%20panel%20also%20recommended%20more%20outcome%20and%20cost-effectiveness%20studies%20to%20assess%20the%20feasibility%20of%20the%20long-term%20clinical%20implementation%20of%20the%20treatment.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1111%5C%2Fner.13094%22%2C%22ISSN%22%3A%221525-1403%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Fner.13094%22%2C%22collections%22%3A%5B%22MKG94YEE%22%5D%2C%22dateModified%22%3A%222020-04-21T11%3A50%3A17Z%22%7D%7D%5D%7D
Goto, Yuko, Koichi Hosomi, Toshio Shimokawa, Takeshi Shimizu, Kiyoshi Yoshino, Seung Jin Kim, Tomoo Mano, Haruhiko Kishima, and Youichi Saitoh. “Pilot Study of Repetitive Transcranial Magnetic Stimulation in Patients with Chemotherapy-Induced Peripheral Neuropathy.” Journal of Clinical Neuroscience 73 (March 1, 2020): 101–7. https://doi.org/10.1016/j.jocn.2020.01.020.
Lefaucheur, Jean-Pascal, André Aleman, Chris Baeken, David H. Benninger, Jérôme Brunelin, Vincenzo Di Lazzaro, Saša R. Filipović, et al. “Evidence-Based Guidelines on the Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS): An Update (2014–2018).” Clinical Neurophysiology 131, no. 2 (February 1, 2020): 474–528. https://doi.org/10.1016/j.clinph.2019.11.002.
Leung, Albert, Prasad Shirvalkar, Robert Chen, Joshua Kuluva, Michael Vaninetti, Richard Bermudes, Lawrence Poree, Eric Wassermann, Brian Kopell, and Robert Levy. “Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS Expert Consensus Panel Review and Recommendation.” Neuromodulation: Technology at the Neural Interface n/a, no. n/a. Accessed April 21, 2020. https://doi.org/10.1111/ner.13094.